GROW YOUR CAPABILITIES

World Vaccine Cell Culture Congress is a technical and process driven conference outlining the means to developing robust, reliable and practical strategies to streamline vaccine bioprocess and scale-up.

The congress is where sponsors, CMOs, media / sera / reagent and cell line providers collaborate to merge technology and process optimization techniques to provide new solutions to existing productivity and efficiency challenges.

2-congress days, 3 plenary session, 30+ speakers

25+ sessions and 16hrs of defined content

10hrs+ of immersive networking events

Get the event prospectus ›

Download the conference brochure ›

Senior cell culture executives attend to uncover:

Cell culture drug development market evolution in the US
Key cell culture applications and incentives
Evolving science enabling enhanced vaccine production
Considerations when moving to cell culture based products
Technical strategies that can maximise efficiencies
Technical strategies adopted by current industry specialists
Technologies enabling expanded product portfolios
Design of optimised clinical and commercial vaccine production
Big Pharma and Biotech involvement and investment

Senior cell culture executives will benefit from content on:

Cell-line engineering vs. cell culture media criteria
Cell line engineering and selection strategies
Media screening and selection methods
Acceptance and application of fed-batch cultures
Vaccine upstream process optimisation
Vaccine process scale-up and downstream integration
Feeding strategies to meet vaccine production needs
Downstream process bottlenecks and challenges
Optimal cultivation and purification processes
Cell culture facility and disposables optimisation

Senior cell culture executive functions you can expect to meet:

Biologic Production / Technology
Biological Production / Manufacturing
Biopharmaceutical Engineering
Bioprocess Development
Bioprocess Technology
Business Development
Cell Culture Development
Cell Technology
Product Development
Project / Quality Management
Upstream Process Development
Downstream Process Development
Filtration / Purification / Separation

5 reasons to attend:

150+ senior vaccines executives all with decision making capacities on their organisation, product or business unit
30+ C-level and VP speakers across strategic, R&D, clinical, manufacturing and cell culture disciplines
50+ exhibitors showcasing their game changing products and services to the vaccine buyers and adopters
40+ research /academic poster sessions in a dedicated forum to promote pre-clinical research and systems biology
4 conferences representing the complete vaccine value chain in one place

What sets World Vaccine Cell Culture Congress apart:

Real peer to peer intelligence: an 85% governmental, pharma and biotech speaker faculty delivers on content
Quality and quantity: over 30 keynotes, case studies, panels and streams offering a comprehensive programme to match your business needs
Meet active decision makers: congress attendees are vetted on their responsibilities to managing bioprocessing campaigns, product units and product supply
A truly global gathering: all major regions and continents represented with over 20 countries in attendance
10hrs of immersive social events: have the means to network with the industry’s cell culture elite

Get the World Vaccine Cell Culture Congress prospectus ›

Download the conference brochure ›

NEW CO-LOCATED BRANDS TO 2012

Innovation and opportunity for pharma, biotech, healthcare and investors

Uncover the greatest unmet needs in immunization
Align portfolios to the 7 key vaccine markets
Reinvent and repurpose their vaccine landscape
Drive pipeline growth and market expansion
Target blockbuster status for existing candidates
Adopt market access best practice for product launch
Position candidates for market approval and authorization
Partner with organizations offering commercial innovation
Best position themselves as key players in the vaccine industry

Vaccine trial optimization for sponsors, CROs and clinical trial sites and eClinical providers

Advance your clinical trials effectively and efficiently and overcome the biggest hurdle to placing your vaccine candidate on the market. Learn about:

An evolving model for vaccine clinical trials and R&D
Globalisation of the vaccine clinical trial model
Reducing attrition in the vaccine clinical trial process
Optimising clinical trial outsourcing partnerships
Site selection and study conduct prioritisation
Efficient patient recruitment and retention
Efficient clinical data collection and management
Clinical trial endpoints vs. real-world endpoints
Implementing innovative adaptive clinical design
eClinical trial technologies and improved efficiency
Overcoming increasingly stringent regulation
Collaborative strategies for regulatory approval outcomes

Production and manufacture process optimization for pharma, biotech and contract partners

Adopt production capabilities and establish robust and efficient manufacturing processes for vaccine development and manufacturing advances. Learn about: